Filter your results
- 3
- 1
- 4
- 4
- 2
- 1
- 1
- 4
- 4
- 4
- 4
- 4
- 3
- 2
- 1
- 1
- 3
- 3
- 3
- 3
- 3
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Comorbidities Are Associated with Fibrosis in NAFLD Subjects: A Nationwide Study (NASH-CO Study)Digestive Diseases and Sciences, 2021, ⟨10.1007/s10620-021-07032-z⟩
Journal articles
hal-03267103v1
|
||
|
The burden of NAFLD in type 2 diabetic subjects from the general population: A Nationwide population-based follow-up study (NASHCO)Liver International, 2022, 42 (3), pp.595-606. ⟨10.1111/liv.15171⟩
Journal articles
hal-03604061v1
|
||
Reply by AuthorsHepatology, 2022, hep.32649. ⟨10.1002/hep.32649⟩
Journal articles
hal-03777509v1
|
|||
|
Prevalence and Risk Factors of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in General Population: the French Nationwide NASH-CO StudyGastroenterology, 2020, 159 (2), pp.791-793.e2. ⟨10.1053/j.gastro.2020.04.048⟩
Journal articles
hal-02975156v1
|